Seahorse Bioscience: Agilent (A) Completes $235M Seahorse Bioscience Buyout
Agilent Technologies Inc. (A) recently completed the acquisition of Seahorse Bioscience in a cash deal worth $235 million. The deal was announced on Sep 9.
Read full article »
Seahorse Bioscience develops and manufactures instruments and assay kits for measuring cell metabolism and bioenergetics.
Read more